MedTrace Logo

Weekly Versus Three-week Chemoradiation in Patients With Advanced Cervical Cancer

NCT01097252 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2014-05-09

No results posted yet for this study

Summary

Three weekly cisplatin based chemoradiation is to be compared the compliance, toxicity, and response rates with the weekly cisplatin based chemoradiation in the treatment of locoregionally advanced cervical cancers.

Conditions

Interventions

RADIATION

radiation

radiation with cisplatin 40mg/m2, 6 cycles, every week

DRUG

weekly cisplatin

weekly cisplatin 40mg/m2, 6 cycles

DRUG

tri-weekly cisplatin

cisplatin 75mg/m2, 3cycles, every 3 weeks

Sponsors & Collaborators

  • Korea Cancer Center Hospital

    lead OTHER

Principal Investigators

  • Sang-Young Ryu, MD · Korea Institute of Radiological & Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-01-31
Primary Completion
2004-12-31
Completion
2009-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01097252 on ClinicalTrials.gov